Paid Clinical Trials for Human Immunodeficiency Virus

Showing all 6 results

Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors

by CTG

in Human Immunodeficiency Virus, End Stage Renal Disease

Other

Louisiana

Deadline:

11/01/2026

V+PSF-M for Tobacco Cessation in HIV Care in India

by CTG

in Smoking Cessation, Human Immunodeficiency Virus, Smoking, Tobacco

Other

Colorado

Deadline:

07/22/2026

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

by CTG

in JC Virus Infection, Malignant Neoplasm, Human Immunodeficiency Virus, BK Virus Infection, Acquired Immunodeficiency Syndrome

Other

Texas

Deadline:

07/31/2027

Harm Reduction in HIV Primary Care for PLWH Who Use Drugs

by CTG

in Human Immunodeficiency Virus, Stigma, Social, Substance Use

Other

Alabama

Deadline:

06/30/2026

Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy

by CTG

in Human Immunodeficiency Virus

Other

Maryland

Deadline:

01/24/2029

Baricitinib for Reduction of HIV – CNS

by CTG

in Human Immunodeficiency Virus

Other

Georgia

Deadline:

01/01/2028

Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors

V+PSF-M for Tobacco Cessation in HIV Care in India

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy

Baricitinib for Reduction of HIV – CNS

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials for Human Immunodeficiency Virus

Filter Results:

Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors

V+PSF-M for Tobacco Cessation in HIV Care in India

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

Harm Reduction in HIV Primary Care for PLWH Who Use Drugs

Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy

Baricitinib for Reduction of HIV – CNS

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps